Logo Image
News
OncClubAll Oncology NewsClinical Trials in Focus
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Conference CoverageConference Listing
Events
Giants of Cancer CareCME/CEScientific InterchangesState of the Science SummitNational Fellows ForumWebinars
More
Partners
Publications
All PublicationsSupplements
Resources
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker Consortium

Subscribe

  • News
  • Watch
  • Conferences
  • Events
  • Partners
  • Publications
  • Resources
  • Biomarker Consortium
  • Subscribe
  • AI for Oncology
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
    • HER2+ Breast Cancer
  • CAR T-Cell Therapy
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
    • Pancreatic Cancer
    • Hepatocellular Carcinoma
    • Gastric Cancer
    • Colorectal Cancer
  • Genitourinary Cancers
    • Urothelial Cancer
    • Prostate Cancer
  • Global Oncology
  • Graft-vs-Host Disease
  • Gynecologic Oncology
    • Ovarian Cancer
  • Head & Neck Cancers
  • Hematologic Oncology
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myeloproliferative Neoplasms
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Oncology Business Management
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Sarcomas
  • Supportive Care
Spotlight -
The OncLive Insider app is live!|
CME Opportunities
Advertisement

Doug Moeller, MD

Advertisement

Articles by Doug Moeller, MD

Unlocked Genomes Provide Clinical Answers, But Questions About Universal Test Catalog Remain

ByDoug Moeller, MD
March 17th 2014

Although we've known for decades that heredity is a major factor in cancer susceptibility and management, the insights gained in the past decade are still breathtaking.

Advertisement

Latest Updated Articles

  • Unlocked Genomes Provide Clinical Answers, But Questions About Universal Test Catalog Remain
    Unlocked Genomes Provide Clinical Answers, But Questions About Universal Test Catalog Remain

    March 17th 2014



Advertisement
Advertisement

Trending on OncLive

1

Triplet Immunotherapy Regimen Yields Durable Responses in pMMR CRPC

2

Talk of Cure, a New ADC, and a Negative Trial: Breaking Down the Biggest Gynecologic Cancer News From ASCO 2026

3

FDA-Approved ADCs Prompt the Need for Revisions to the Breast Cancer Management Roadmap

4

Phase 1 Data Set the Stage for Further Exploration of Cevostamab in R/R Myeloma

5

Emerging Maintenance Strategies May be the Key to Extending Survival in ES-SCLC

  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo
Download on Apple
Download on Google Play

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us